Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients

Genes Chromosomes and Cancer

Volumn 51, Issue 8, 2012, Pages 727-742

  Martin, Lorri D ^a   Harizanova, Jana ^b,c   Zhu, George ^a   Righolt, Christiaan H ^b,d   Belch, Andrew R ^a   Mai, Sabine ^b   Pilarski, Linda M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^d DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CCNDI PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; IGH PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CANCER PATIENT; CELL NUCLEUS; COMPUTER PROGRAM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL;

B-LYMPHOCYTES; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELL NUCLEUS; CYCLIN D1; DNA, INTERGENIC; GENETIC LOCI; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; MULTIPLE MYELOMA; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; TRANSLOCATION, GENETIC;

EID: 84861675925     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21959     Document Type: Article

References (44)

1. Adamia S, Reiman T, Crainie M, Mant MJ, Belch AR, Pilarski LM. 2005. Intronic splicing of hyaluronan synthase 1 (HAS1): A biologically relevant indicator of poor outcome in multiple myeloma. Blood 105: 4836-4844.
2. Aten JA, Stap J, Krawczyk PM, van Oven CH, Hoebe RA, Essers J, Kanaar R. 2004. Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains. Science 303: 92-95.
3. Bergsagel PL, Kuehl WM. 2005. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 23: 6333-6338.
4. Biggs DCS. 2004. Clearing up deconvolution. Biophotonics Int 32-37.
5. Branco MR, Pombo A. 2006. Intermingling of chromosome territories in interphase suggests role in translocations and transcription-dependent associations. PLoS Biol 4: e138.
6. Cremer M, Grasser F, Lanctot C, Muller S, Neusser M, Zinner R, Solovei I, Cremer T. 2008. Multicolor 3D fluorescence in situ hybridization for imaging interphase chromosomes. Methods Mol Biol 463: 205-239.
7. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD, Jr., Stewart AK, Avet-Loiseau H. 2004. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 64:1546-1558.
8. Fukita Y, Jacobs H, Rajewsky K. 1998. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity 9: 105-114.
9. Gonzalez D, van der Burg M, Garcia-Sanz R, Fenton JA, Langerak AW, Gonzalez M, van Dongen JJ, San Miguel JF, Morgan GJ. 2007. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood 110: 3112-3121.
10. Harizanova J, Taylor-Kashton C, Mai S. 2008. Summary of the quantitative analyses of the three-dimensional distribution of chromosomes in mouse cells. Am Assoc Cancer Res 809.
11. Holmes TJ, Bhattacharyya S, Cooper JA, Hanzel D, Krishnamurthi V, Lin W, Roysam B, Szarowski DH, Turner JT. 1995. Light microscopic images reconstructed by maximum likelihood deconvolution. In: Pawley J, editor. The Handbook of Biological Confocal Microscopy, 2nd ed. New York: Plenum Press. p 389-402.
12. Kirshner J, Thulien KJ, Martin LD, Debes Marun C, Reiman T, Belch AR, Pilarski LM. 2008. A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma. Blood 112: 2935-2945.
13. Lever E, Sheer D. 2010. The role of nuclear organization in cancer. J Pathol 220: 114-125.
14. Lin C, Yang L, Tanasa B, Hutt K, Ju BG, Ohgi K, Zhang J, Rose DW, Fu XD, Glass CK, Rosenfeld MG. 2009. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139: 1069-1083.
15. Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, Kleinstein SH, Schatz DG. 2008. Two levels of protection for the B cell genome during somatic hypermutation. Nature 451: 841-845.
16. Mani RS, Tomlins SA, Callahan K, Ghosh A, Nyati MK, Varambally S, Palanisamy N, Chinnaiyan AM. 2009. Induced chromosomal proximity and gene fusions in prostate cancer. Science 326: 1230.
17. Martin LD, Belch AR, Pilarski LM. 2010. Promiscuity of translocation partners in multiple myeloma. J Cell Biochem 109: 1085-1094.
18. Mathas S, Kreher S, Meaburn KJ, Johrens K, Lamprecht B, Assaf C, Sterry W, Kadin ME, Daibata M, Joos S, Hummel M, Stein H, Janz M, Anagnostopoulos I, Schrock E, Misteli T, Dorken B. 2009. Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci USA 106: 5831-5836.
19. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ. 2004. Characterization of clonogenic multiple myeloma cells. Blood 103: 2332-2336.
20. Meaburn KJ, Misteli T. 2008. Locus-specific and activity-independent gene repositioning during early tumorigenesis. J Cell Biol 180: 39-50.
21. Meaburn KJ, Gudla PR, Khan S, Lockett SJ, Misteli T. 2009. Disease-specific gene repositioning in breast cancer. J Cell Biol 186: 801-812.
22. Mitelman F, Johansson B, Mertens F. 2007. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7: 233-245.
23. Neves H, Ramos C, da Silva MG, Parreira A, Parreira L. 1999. The nuclear topography of ABL, BCR, PML, and RARalpha genes: Evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood 93: 1197-1207.
24. Nikiforova MN, Stringer JR, Blough R, Medvedovic M, Fagin JA, Nikiforov YE. 2000. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290: 138-141.
25. Nussenzweig A, Nussenzweig MC. 2010. Origin of chromosomal translocations in lymphoid cancer. Cell 141: 27-38.
26. Osborne CS, Chakalova L, Brown KE, Carter D, Horton A, Debrand E, Goyenechea B, Mitchell JA, Lopes S, Reik W, Fraser P. 2004. Active genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet 36: 1065-1071.
27. Osborne CS, Chakalova L, Mitchell JA, Horton A, Wood AL, Bolland DJ, Corcoran AE, Fraser P. 2007. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biol 5: e192.
28. Parada LA, McQueen PG, Misteli T. 2004. Tissue-specific spatial organization of genomes. Genome Biol 5: R44.
29. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, Dalla-Favera R. 2001. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412: 341-346.
30. Peters A, Storb U. 1996. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4: 57-65.
31. Pilarski LM, Pruski E, Wizniak J, Paine D, Seeberger K, Mant MJ, Brown CB, Belch AR. 1999. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells. Blood 93: 2918-2927.
32. Pilarski LM, Baigorri E, Mant MJ, Pilarski PM, Adamson P, Zola H, Belch AR. 2008. Multiple myeloma includes phenotypically defined subsets of clonotypic CD20+ B cells that persist during treatment with rituximab. Clin Med Oncol 2: 275-287.
33. Ragoczy T, Telling A, Sawado T, Groudine M, Kosak ST. 2003. A genetic analysis of chromosome territory looping: Diverse roles for distal regulatory elements. Chromosome Res 11: 513-525.
34. Reiman T, Seeberger K, Taylor BJ, Szczepek AJ, Hanson J, Mant MJ, Coupland RW, Belch AR, Pilarski LM. 2001. Persistent preswitch clonotypic myeloma cells correlate with decreased survival: Evidence for isotype switching within the myeloma clone. Blood 98: 2791-2799.
35. Ridler TW, Calvard S. 1978. Picture thresholding using an iterative selection method. IEEE Trans Syst Man Cybern 8: 630-632.
36. Robbiani DF, Bothmer A, Callen E, Reina-San-Martin B, Dorsett Y, Difilippantonio S, Bolland DJ, Chen HT, Corcoran AE, Nussenzweig A, Nussenzweig MC. 2008. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135: 1028-1038.
37. Roix JJ, McQueen PG, Munson PJ, Parada LA, Misteli T. 2003. Spatial proximity of translocation-prone gene loci in human lymphomas. Nat Genet 34: 287-291.
38. Sarkar R, Guffei A, Vermolen BJ, Garini Y, Mai S. 2007. Alterations of centromere positions in nuclei of immortalized and malignant mouse lymphocytes. Cytometry Part A 71A: 386-392.
39. Schrader CE, Guikema JE, Linehan EK, Selsing E, Stavnezer J. 2007. Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. J Immunol 179: 6064-6071.
40. Soutoglou E, Misteli T. 2008. On the contribution of spatial genome organization to cancerous chromosome translocations. J Natl Cancer Inst Monogr 16-19.
41. Soutoglou E, Dorn JF, Sengupta K, Jasin M, Nussenzweig A, Ried T, Danuser G, Misteli T. 2007. Positional stability of single double-strand breaks in mammalian cells. Nat Cell Biol 9: 675-682.
42. Szczepek AJ, Seeberger K, Wizniak J, Mant MJ, Belch AR, Pilarski LM. 1998. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood 92: 2844-2855.
43. Takizawa T, Meaburn KJ, Misteli T. 2008. The meaning of gene positioning. Cell 135: 9-13.
44. Tsai AG, Lu H, Raghavan SC, Muschen M, Hsieh CL, Lieber MR. 2008. Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell 135: 1130-1142.